Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinglin Chen

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Toxicology in Vitro : an International Journal Published in Association with BIBRA|April 24, 2024
Bisphenol S enhances the cell proliferation ability of prostate cancer cells by regulating the expression of SDSGuanqun Ju, Xiangyang Zhan, Xinglin Chen, et al.
Entropy (Basel, Switzerland)|September 27, 2024
Enhanced Magnetocaloric Properties of the (MnNi)<sub>0.6</sub>Si<sub>0.62</sub>(FeCo)<sub>0.4</sub>Ge<sub>0.38</sub> High-Entropy Alloy Obtained by Co SubstitutionZhigang Zheng, Pengyan Huang, Xinglin Chen, et al.
Translational Andrology and Urology|September 18, 2020
Predictive value of preoperative comprehensive evaluation on the efficacy of HoLEPXinglin Chen, Qiuhong Man, Xiyi Wei, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 12, 2026
Antibody-Empowered Nanomedicine for Precise Biomedical ApplicationsChen Chen, Xinglin Chen, Zhenhao Gao, et al.
International Journal of Environmental Research and Public Health|November 4, 2020
Disease Outbreak, Health Scare, and Distance Decay: Evidence from HPAI Shocks in Chinese Meat SectorLan Yi, Congcong Duan, Jianping Tao, et al.
Frontiers in Immunology|November 21, 2022
Identifying tumor antigens and immune subtypes of renal cell carcinoma for immunotherapy developmentXinglin Chen, Tongtong Zhang, Xinyu Zhai, et al.
Frontiers in Genetics|July 26, 2021
Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell CarcinomaYuang Wei, Xinglin Chen, Xiaohan Ren, et al.
European Journal of Medical Research|November 7, 2023
PPARG is a potential target of Tanshinone IIA in prostate cancer treatment: a combination study of molecular docking and dynamic simulation based on transcriptomic bioinformaticsTongtong Zhang, Xinglin Chen, Xiran Ju, et al.
Molecules (Basel, Switzerland)|March 13, 2024
Research Progress of Ozone/Peroxymonosulfate Advanced Oxidation Technology for Degrading Antibiotics in Drinking Water and Wastewater Effluent: A ReviewHai Lu, Xinglin Chen, Qiao Cong, et al.
The EPMA Journal|May 19, 2020
Early decrease in blood platelet count is associated with poor prognosis in COVID-19 patients-indications for predictive, preventive, and personalized medical approachXiaofang Zhao, Kun Wang, Peiyuan Zuo, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Toxicology in Vitro : an International Journal Published in Association with BIBRA|April 24, 2024
Bisphenol S enhances the cell proliferation ability of prostate cancer cells by regulating the expression of SDSGuanqun Ju, Xiangyang Zhan, Xinglin Chen, et al.
Entropy (Basel, Switzerland)|September 27, 2024
Enhanced Magnetocaloric Properties of the (MnNi)<sub>0.6</sub>Si<sub>0.62</sub>(FeCo)<sub>0.4</sub>Ge<sub>0.38</sub> High-Entropy Alloy Obtained by Co SubstitutionZhigang Zheng, Pengyan Huang, Xinglin Chen, et al.
Translational Andrology and Urology|September 18, 2020
Predictive value of preoperative comprehensive evaluation on the efficacy of HoLEPXinglin Chen, Qiuhong Man, Xiyi Wei, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 12, 2026
Antibody-Empowered Nanomedicine for Precise Biomedical ApplicationsChen Chen, Xinglin Chen, Zhenhao Gao, et al.
International Journal of Environmental Research and Public Health|November 4, 2020
Disease Outbreak, Health Scare, and Distance Decay: Evidence from HPAI Shocks in Chinese Meat SectorLan Yi, Congcong Duan, Jianping Tao, et al.
Frontiers in Immunology|November 21, 2022
Identifying tumor antigens and immune subtypes of renal cell carcinoma for immunotherapy developmentXinglin Chen, Tongtong Zhang, Xinyu Zhai, et al.
Frontiers in Genetics|July 26, 2021
Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell CarcinomaYuang Wei, Xinglin Chen, Xiaohan Ren, et al.
European Journal of Medical Research|November 7, 2023
PPARG is a potential target of Tanshinone IIA in prostate cancer treatment: a combination study of molecular docking and dynamic simulation based on transcriptomic bioinformaticsTongtong Zhang, Xinglin Chen, Xiran Ju, et al.
Molecules (Basel, Switzerland)|March 13, 2024
Research Progress of Ozone/Peroxymonosulfate Advanced Oxidation Technology for Degrading Antibiotics in Drinking Water and Wastewater Effluent: A ReviewHai Lu, Xinglin Chen, Qiao Cong, et al.
The EPMA Journal|May 19, 2020
Early decrease in blood platelet count is associated with poor prognosis in COVID-19 patients-indications for predictive, preventive, and personalized medical approachXiaofang Zhao, Kun Wang, Peiyuan Zuo, et al.
Pageof 9